Analysis of patients with breast cancer showed that the expression status of the estrogen receptor might determine the role of RNF5 in breast cancers and that low RNF5 expression was correlated with better overall survival in patients with estrogen receptor-positive breast cancers (Fig. 6B). Here, ESR1 is linked to breast carcinoma.